Action is required to reduce kava supply in Arnhem Land . . . again!

Alan R Clough, Bart J Currie, Maymuna W Yunupingu and Katherine M Conigrave
Med J Aust 2006; 184 (2): 91-92.

Alan R Clough,* Bart J Currie, Maymuna W Yunupingu, Katherine M Conigrave§

Please login with your free MJA account to view this article in full

  • Alan R Clough2
  • Bart J Currie3
  • Maymuna W Yunupingu4
  • Katherine M Conigrave4

  • 1 Institute of Advanced Studies, Menzies School of Health Research, Charles Darwin University, PO Box 1479, Nhulunbuy, NT 0881
  • 2 and Head, Tropical and Emerging Infectious Diseases Division, Menzies School of Health Research, Charles Darwin University, and Northern Territory Clinical School, Flinders University, Royal Darwin Hospital, Darwin, NT
  • 3 NT Department of Health and Community Services, Yirrkala, NT
  • 4 Royal Prince Alfred Hospital and University of Sydney, Sydney, NSW.



The research reported here is supported by a National Health and Medical Research Council Postdoctoral Training Fellowship.

Competing interests:

Alan Clough has been a member of the Northern Territory Licensing Commission, the body responsible for licensing kava in the Northern Territory.

  • 1. Northern Territory of Australia. Kava. Darwin: Northern Territory Treasury, Racing, Gaming and Licensing Division, 2005. Available at: (accessed Sep 2005).
  • 2. Clough AR. Enough! or too much. What is “excessive” kava use in Arnhem Land? Drug Alcohol Rev 2003; 22: 43-51.
  • 3. d’Abbs P. A review of kava control measures in the Northern Territory. Darwin: Menzies School of Health Research, 1993.
  • 4. Clough AR, Jacups SP, Wang Z, et al. Health effects of kava use in an eastern Arnhem Land community. Intern Med J 2003; 33: 336-340.
  • 5. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 2000; 31: 981-986.
  • 6. Currie BJ, Clough AR. Kava hepatoxicity with Western herbal products: does it occur with traditional kava use? Med J Aust 2003; 178: 421-422. <MJA full text>


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.